2,6-Difluoroanisole

We are 2,6-Difluoroanisole CAS:437-82-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,6-Difluoroanisole
CAS.NO:437-82-1
Synonyms:2,6-Difluoroanisole
1,3-Difluoro-2-methoxybenzene
Molecular Formula:C7H6F2O
Molecular Weight:144.11900
 
Physical and Chemical Properties:
Density:1.221
Boiling point:70-72ºC
Flash point:61ºC
Index of Refraction:1.452
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,6-Difluoroanisole


Related News: An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.benzyl 2,3,3a,4,5,6,7,7a-octahydro-1H-indole-2-carboxylate,hydrochloride CAS:145641-35-6 An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.N-Tert-Butoxycarbonyl-4-(4-Toluenesulfonyloxymethyl)Piperidine The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.Epóxido de N- [4-ciano-3- (trifluorometil) fenil] metacrilamida CAS:90357-51-0 Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.

Related Products
Product Name
palmitoleic acid View Details
2-(Chloromethyl)-4-methylquinazoline View Details
trichloro(dichloromethyl)silane View Details
4-Nitrophenyl isocyanate manufacturer 4-phenyl-N-[4-(9-phenylcarbazol-3-yl)phenyl]aniline manufacturer 2-Ethoxy-3-methylpyrazine manufacturer (Z)-Guggulsterone manufacturer ethyl (2S,3R)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,3-dihydroxy-2-methylpropanoate manufacturer